SCHEMBL19976804

SCHEMBL19976804

CC(C)(C)N/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2c(C(F)(F)F)cccc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.37
EGFR P00533 1/20 0.34
SSTR4 P31391 1/20 0.33
CHRNA1 P02708 1/20 0.32
CHRNG P07510 1/20 0.32
CHRNB1 P11230 1/20 0.32
CHRNB2 P17787 1/20 0.32
SLC6A2 P23975 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
SLC6A3 Q01959 1/20 0.32
CHRND Q07001 1/20 0.32
HDAC6 Q9UBN7 4/20 0.32
HDAC1 Q13547 1/20 0.31
AURKA O14965 1/20 0.31
RPS6KB1 P23443 1/20 0.31
ANO1 Q5XXA6 2/20 0.31
CDK1 P06493 2/20 0.31
CDK2 P24941 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976801 0.91 TRPA1 (0.37) TRPA1EGFRCHRNA1CHRNGCHRNB1
SCHEMBL19976781 0.86 TRPA1 (0.35) TRPA1EGFRAURKARPS6KB1DYRK1A
SCHEMBL19976730 0.84 HDAC6 (0.41) HDAC6CDK1CDK2GSK3BPLK4
SCHEMBL19976782 0.83 MAPK1 (0.36) TRPA1EGFRHDAC6GSK3BKDR
SCHEMBL19976929 0.82 RIPK1 (0.37) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL19976725 0.81 GSK3B (0.52) TRPA1HDAC6HDAC1GSK3BMAPK8
SCHEMBL19976736 0.81 MAP2K4 (0.44) TRPA1HDAC6AURKACDK1CDK2
SCHEMBL19976726 0.79 ABL1 (0.41) EGFRCHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL19976765 0.79 NTRK1 (0.41) HDAC6AURKAANO1CDK1CDK2
SCHEMBL16752855 0.79 CHRNA1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed